Genentech, Breast Cancer
PI3K Inhibitor Wins FDA Approval for Advanced Breast Cancer
The FDA approved the PI3K-pathway inhibitor inavolisib (Itovebi) for use in combination with palbociclib (Ibrance) and fulvestrant to treat locally advanced, PIK3CA -mutated, hormone receptor (HR)-positive/HER2-negative breast cancer that recurred during or after adjuvant endocrine therapy.
FDA Approves Inavolisib for HR+, HER2−, Advanced Breast Cancer With PIK3CA Mutation
The FDA also approved the FoundationOne Liquid CDx assay to identify patients who qualify for the newly approved treatment. Genentech Executive Levi Garraway, MD, PhD, called the approval "an important new first-line option for people living with HR+ breast cancer with a PIK3CA mutation" in a company press release.
Genentech Itovebi Gets FDA Approval for Treating Breast Cancer
Roche Group unit Genentech said that the Food and Drug Administration approved Itovebi for treating certain breast cancer. The approval is for Itovebi in combination with palbociclib and fulvestrant and for treating adults a certain locally advanced or metastatic breast cancer,
FDA approves Genentech drug aimed at subset of breast cancer patients
A potential blockbuster cancer drug developed by Genentech Inc. and parent company Roche won regulatory approval Thursday to treat a subset of breast cancer patients, more than a month ahead of its scheduled decision date.
FDA Approves Genentech’s Itovebi, a Targeted Treatment for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) approved Itovebi™ (inavolisib), in combination with palbociclib (Ibrance ® ) and fulvestrant,
Breast cancer patient says new type of chemo saved her life: ‘I am thriving’
A medical clinic in Scottsdale, Arizona, offers an alternative, personalized form of chemotherapy designed to target cancer ...
New breast cancer diagnosis technology aims to cut waiting times
A Cork research team has developed a new biopsy technology that aims to reduce waiting times for breast cancer biopsy results ...
Hosted on MSN20h
Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?
As an FDA-mandated rule goes into effect requiring healthcare providers to notify women of their breast density, the American ...
KTTC11m
Taking charge of your health for Breast Cancer Awareness Month
ROCHESTER, Minn. (KTTC) – Each year, the month of October is a global effort to raise awareness for breast cancer. It’s the ...
North Texas woman creates "Pink'd Out House" for Breast Cancer Awareness
Amid the usual orange and black of spooky season, Angela Fincher's house is decked out to raise awareness for breast cancer.
Roche CEO: breast cancer pill could enter $12 bln market if trials succeed
Roche's experimental oral drug for breast cancer giredestrant could enter a market worth at least 10 billion Swiss francs ...
wqad2h
Nurse diagnosed with breast cancer completes nearly 500-mile solo hike weeks after surgery
October is Breast Cancer Awareness Month and Kelly LaMarre is sharing her story to encourage other women to prioritize ...
Two Elgin breast cancer survivors honored Sunday at Chicago Bears Crucial Catch game
Bobbie Jackson and Carmen Rojas, two Elgin women who have survived breast cancer, were honored Sunday at the Chicago Bears ...
New Stand-Up Comedy Event Shows How Humor Gives Hope Vs. Breast Cancer
Actor and comedian Jana Bernard pulled together a diverse line-up of stand-up comics for a show in New York City to benefit ...